investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

David Kozono

Characterization of lung cancer radiosensitizers from genome-wide RNAi screens

Trachea, bronchus and lung

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology

Deborah Morrison

Regulation of Ras-Dependent Signal Transduction Pathways

Trachea, bronchus and lung

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Ashish Lal

Regulation of microRNA expression by Mutant p53

Trachea, bronchus and lung

Susan Bates

Clinical Studies to Circumvent Drug Resistance

Trachea, bronchus and lung

William Stetler-Stevenson

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

Trachea, bronchus and lung

Jonathan M Kurie

Regulation of Lung Cancer Metastasis by ZEB1

Trachea, bronchus and lung